Related Experiment Video
Updated: May 16, 2026

13:59
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
Published on: October 9, 2010
Light-controlled toxicity of engineered amyloid β-peptides
Christian Hoppmann1, Christian Barucker, Dorothea Lorenz
1Department of Chemical Biology, Leibniz-Institut für Molekulare Pharmakologie, Berlin, Germany. choppmann@salk.edu
Chembiochem : a European Journal of Chemical Biology
|November 20, 2012
Abstract:
Aggregation of amyloid β (Aβ(1-42)), causing toxicity, is a critical step in Alzheimer's disease (AD). AD studies are difficult to compare because Aβ(1-42) aggregation is poorly controllable under physiological conditions. To control aggregation and toxicity, we engineered light-switchable Aβ(1-42) analogues that enable controllable conversion of nontoxic fibrils into toxic oligomers simply by illumination.
